admin@smrm2026.com

Abstract Submission Guidelines

Abstract Submission Guidelines

You are invited to submit informative abstracts of up to 300 words which would not include the title of the abstract, author affiliations, and other headings

Important Dates

Last Date for Abstract Submission 30 September 2026
Notification of acceptance for oral/ poster presentations: 15 October 2026
Withdrawal Deadline 05 October 2026

Submission Rules

  • Please read the submission rules before submitting an abstract.
  • Abstracts should be uploaded online. Abstracts will not be accepted on emails or through any other mode.
  • It is mandatory for the presenting author to register for the conference to have the abstract included in the conference proceedings.
  • All abstracts are subject to review by the Scientific Committee. Acceptance in the program is not guaranteed.

The abstracts must be submitted under one of the following categories/sections for Oral or Poster presentation:

  • Clinical
  • Basic Science

The scientific committee reserves the right to accept/ reject/ assign a different presentation type to all the abstracts submitted; if selected.

Abstract Title

Please write the title in sentence case. Do not use quotation marks. Kindly note, the text will be used, as is wherever your abstract title is being used/ printed/ mentioned anywhere.
Example: Impact of artificial intelligence on early disease detection in healthcare.

Authors & Affiliations

  • Corresponding/ Submitting Author: The person submitting the abstract (who’s email ID is used to create the profile) will be single person to whom all correspondence/ communication will be sent.
  • Presenting Author: Details should be entered in the provided fields (even if the corresponding author is the presenting author of the abstract).
  • Co-authors & Affiliations: The system has a box to enter the number of co-authors. Details of each of the co-authors with their affiliations should be submitted while submitting the abstract.

Abstract Text

Abstracts should follow the format outlined below.

  • Background
  • Aim and objectives
  • Methods
  • Results
  • Conclusions

Conflict of Interest Statement

If the research described in the abstract was supported by a commercial company, you must indicate the company's role in analysing the data or preparing the abstract. One of the following must appear at the bottom of the abstract:

  • No conflict of interest to disclose.
  • This research was supported by __________. The company had no role in analysing the data or preparing the abstract.
  • This research was supported by __________. The company inserts free text describing company role in data analysis or abstract preparation.

This conflict-of-interest statement is mandatory for all abstracts submitted and will appear wherever & if the abstracts are published.

Important Notes

  • All abstracts should be submitted and presented in English with accurate grammar and spelling of a quality suitable for publication.
  • Submission of the abstract carries with it an obligation to present the accepted abstract in person without any change in scientific content during the allotted time in the above conference.
  • Withdrawal of presentation should be intimated to the scientific committee on or before 05 October, 2026
  • If the presenting author (mentioned while submitting the abstract) is not able to present the paper at the conference due to any reason, prior permission must be obtained from the Scientific Committee regarding the change in the presenting author.
  • Preference for oral or poster presentation may be indicated at the time of submission of abstract though the final decision of the scientific committee will be binding.
  • More than 1 Abstract can be submitted by any individual Author.
  • Top 3 Posters for clinical and basic science categories will be announced at the end of the meeting, during Valedictory Ceremony.
  • Please do not submit multiple copies of the same abstract. If such a case is found, the abstract received second time will be considered, and retrieval of the older one will not be possible.
  • An acknowledgement with an identification (unique) number shall be shared with you on receipt of your abstract. Please refer to this abstract number in all correspondence regarding the abstract. Do check your spam/ junk folder if you do not see an acknowledgement in your mailbox.